7301 - 7325 of 9140 Results
Title
Year
- Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s Disease2018RESTRICTEDTitle: Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson’s DiseaseJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 56Issue #: 1Start Page: 688End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s12035-018-1109-6Citation Count: 66
- Insufficient effect of deep brain stimulation in a patient with KCNN2-associated myoclonus-dystonia2025RESTRICTEDTitle: Insufficient effect of deep brain stimulation in a patient with KCNN2-associated myoclonus-dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 131Issue #:Start Page: 107260End Page: 107260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107260Citation Count: 6
-
OPENTitle: Reliability of remote video ratings of the scale for assessment and rating of ataxiaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 132Issue #:Start Page: 107278End Page: 107278Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.107278Best OA location URL: https://www.prd-journal.com/article/S1353-8020(25)00019-7/pdfCitation Count: 4
-
OPENTitle: Longitudinal brain morphometry in Parkinson's disease clinical subtypes: Distinct signatures forecast behavioral change within subtypesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 142Issue #:Start Page: 108141End Page: 108141Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108141Best OA location URL: https://www.prd-journal.com/article/S1353-8020(25)00890-9/pdfCitation Count: 0
- Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study2017RESTRICTEDTitle: Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 9Start Page: 1335End Page: 1336Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27092Citation Count: 13
- A pilot study of human brain tissue post-magnetic resonance imaging: Information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN)2010RESTRICTEDTitle: A pilot study of human brain tissue post-magnetic resonance imaging: Information from the National Deep Brain Stimulation Brain Tissue Network (DBS-BTN)Journal Name: NeuroImagePublisher: Elsevier BVVol: 54Issue #:Start Page: S233End Page: S237Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2010.09.014Citation Count: 10
- History of high household pesticide use and Parkinson's disease in Brazil2023RESTRICTEDTitle: History of high household pesticide use and Parkinson's disease in BrazilJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 113Issue #:Start Page: 105493End Page: 105493Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105493Citation Count: 11
-
OPENTitle: Anti‐Parkinsonian and anti‐dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 175Issue #: 5Start Page: 782End Page: 796Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.14123Best OA location URL: https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bph.14123Citation Count: 22
- A turn for the worse: Turning performance in Parkinson's disease and Essential tremor2019RESTRICTEDTitle: A turn for the worse: Turning performance in Parkinson's disease and Essential tremorJournal Name: Clinical BiomechanicsPublisher: Elsevier BVVol: 70Issue #:Start Page: 245End Page: 248Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiomech.2019.09.008Citation Count: 7
-
OPENTitle: Clinical and Neuropathological Features Associated With Loss of RAB39BJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 4Start Page: 687End Page: 693Publication Date:Open Access(OA) Status: OPENLicense: public-domainDOI - Digital Object Identifier: 10.1002/mds.27951Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27951Citation Count: 22
-
OPENTitle: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activationJournal Name: Brain Research BulletinPublisher: Elsevier BVVol: 179Issue #:Start Page: 74End Page: 82Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8849140Citation Count: 9
-
OPENTitle: A role for the autophagy receptor NBR1 in the degradation of tau aggregatesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 214Issue #:Start Page: 107060End Page: 107060Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2025.107060Best OA location URL: https://doi.org/10.1016/j.nbd.2025.107060Citation Count: 3
- Reliability, Validity, and Sensitivity to Change of the Lower Extremity Functional Scale in Individuals Affected by Stroke2013RESTRICTEDTitle: Reliability, Validity, and Sensitivity to Change of the Lower Extremity Functional Scale in Individuals Affected by StrokeJournal Name: PM&RPublisher: WileyVol: 5Issue #: 12Start Page: 1019End Page: 1025Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pmrj.2013.07.001Citation Count: 29
- Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.2014RESTRICTEDTitle: Differential effects of goal cues on everyday action errors in Alzheimer’s disease versus Parkinson’s disease dementia.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 29Issue #: 4Start Page: 592End Page: 602Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/neu0000167Citation Count: 25
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://doaj.org/article/8d8cf4f9837744e3b7e12b8b5fafeecfCitation Count: 50
- Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's disease2017RESTRICTEDTitle: Inflammatory profile discriminates clinical subtypes in LRRK2‐associated Parkinson's diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 2Start Page: 427End Page: 427Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13223Citation Count: 55
-
OPENTitle: Classification of pallidal oscillations with increasing parkinsonian severityJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 1Start Page: 209End Page: 218Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00840.2014Best OA location URL: http://doi.org/10.1152/jn.00840.2014Citation Count: 21
-
OPENTitle: Aberrant Cerebellar-Recipient Thalamic Activity in Two Mouse Models with Prominent Tremor or BradykinesiaJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 46Issue #: 19Start Page: e1630252026End Page: e1630252026Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1630-25.2026Best OA location URL: https://doi.org/10.1523/jneurosci.1630-25.2026Citation Count: 0
- A liver–mitochondria–immune axis in Parkinson’s disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson’s disease2026RESTRICTEDTitle: A liver–mitochondria–immune axis in Parkinson’s disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson’s diseaseJournal Name: Current Opinion in ImmunologyPublisher: Elsevier BVVol: 100Issue #:Start Page: 102761End Page: 102761Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.coi.2026.102761Citation Count: 0
-
OPENTitle: Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET studyJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 12Issue #:Start Page: 100353End Page: 100353Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2025.100353Best OA location URL: https://doi.org/10.1016/j.prdoa.2025.100353Citation Count: 5
-
RESTRICTEDTitle: Theoretical Optimization of Stimulation Strategies for a Directionally Segmented Deep Brain Stimulation Electrode ArrayJournal Name: IEEE Transactions on Biomedical EngineeringPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 63Issue #: 2Start Page: 359End Page: 371Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1109/tbme.2015.2457873Best OA location URL: http://doi.org/10.1109/TBME.2015.2457873Citation Count: 35
- Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug Strategy2018RESTRICTEDTitle: Increased Brain Exposure of an Alpha-Synuclein Fibrillization Modulator by Utilization of an Activated Ester Prodrug StrategyJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 11Start Page: 2542End Page: 2547Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.8b00236Citation Count: 12
-
OPENTitle: The G2019S mutation in LRRK2 imparts resiliency to kinase inhibitionJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 309Issue #:Start Page: 1End Page: 13Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.012Best OA location URL: https://doi.org/10.1016/j.expneurol.2018.07.012Citation Count: 46
-
OPENTitle: Extracellular Vesicle‐Mediated Delivery of Constrained Peptides Disrupts the Pathogenic Interaction of LRRK2‐FADD in Parkinson's DiseaseJournal Name: Journal of Extracellular BiologyPublisher: WileyVol: 5Issue #: 2Start Page: e70116End Page: e70116Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/jex2.70116Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jex2.70116Citation Count: 2
-
OPENTitle: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET RadioligandJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 22Start Page: 4210End Page: 4219Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493Best OA location URL: https://doi.org/10.1021/acschemneuro.4c00493Citation Count: 7